Overall, the study provides some inspiring data and indicates INH administration effectively improved cognitive performance, cleared Aβ plaques, protected dendritic synapses and reduced innate immune cells around the Aβ plaques in APP/PS1 mice, suggesting that INH could be a potential drug for AD treatment. Here, APP is linked to Alzheimer disease.